Although some of the lncRNAs investigated in our work have been described as biomarkers in other disorders and lncRNA H19 shows evidence to be a diagnostic biomarker for cardiovascular diseases, no specific data have been reported in the setting of AAA [48]. Here, H19 is linked to triple-A syndrome.